medigraphic.com
ISSN 0016-3813 (Impreso)

2014, Número s3

<< Anterior Siguiente >>

Gac Med Mex 2014; 150 (s3)


Evolución del tratamiento endovascular comparado con el tratamiento médico y el quirúrgico en pacientes con síndrome aórtico agudo de tipo B

Eid-Lidt G, Hernández JG, González-Pacheco H, Meléndez- Ramírez G, Molina MJ, Cervantes SJL, Ramírez MS

Idioma: Español
Referencias bibliográficas: 34
Paginas: 298-305
Archivo PDF: 270.84 Kb.


RESUMEN

Introducción: El tratamiento convencional del síndrome aórtico agudo (SAA) de tipo B en pacientes con complicaciones isquémicas es el tratamiento quirúrgico (TQ). Los resultados prometedores del tratamiento endovascular (TEV) han expandido su indicación a una variedad de enfermedades de la aorta torácica. Objetivos: El objetivo del estudio fue evaluar la seguridad y eficacia del TEV comparado con el tratamiento médico (TM) y el TQ durante la fase hospitalaria y a mediano plazo, en pacientes con SAA de tipo B. Materiales y métodos: De los 113 pacientes que reunieron los criterios de inclusión, 58 fueron sometidos a TEV (grupo 1), 34, a tratamiento médico (grupo 2) y 21, a TQ (grupo 3). Resultados: La mortalidad global hospitalaria y cardiovascular (CV) fue superior en el grupo 3 (p = 0.0001), al igual que la tasa de eventos adversos (p = 0.0001). El seguimiento fue de 30.4 ± 12.2 meses en la población global. La supervivencia libre de muerte CV fue del 92.5, el 60.5 y el 42.9% a los 36 meses en los grupos 1, 2 y 3, respectivamente. Conclusiones: Nuestros resultados indican que, comparado con el TM y el TQ, el TEV en pacientes con SAA de tipo B es factible y seguro, y presenta una adecuada supervivencia libre de muerte CV.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Vilacosta I, San Roman JA. Acute aortic syndrome. Heart. 2001;85: 365-8.

  2. Nienaber CA, Powell JT. Management of acute aortic syndromes. Eur Heart J. 2012;33:26-35.

  3. Evangelista A, Padilla F, López-Ayerbe J, et al. Spanish acute aortic syndrome study (RESA). Better diagnosis is not reflected in reduced mortality. Rev Esp Cardiol. 2009;62:255-62.

  4. Tsai TT, Fattori R, Trimarchi S, et al. Long-term survival in patients presenting with type B acute aortic dissection. Insights from the international registry of acute aortic dissection. Circulation. 2006;114:2226-31.

  5. Clough RE, Mani K, Lyons OT, et al. Endovascular treatment of acute aortic syndrome. J Vasc Surg. 2011;54:1580-7.

  6. Grabenwoger M, Alfonso F, Bachet J, et al. Thoracic endovascular aortic repair (TEVAR) for the treatment of aortic diseases: a position statement from the European Association for Cardio-Thoracic Surgery (EACTS) and the European Society of Cardiology (ESC), in collaboration with the European Association of Percutaneous Cardiovascular Intervention (EAPCI): Eur Heart J. 2012;33:1558-63.

  7. Nienaber C, Fattori R, Lund G, et al. Nonsurgical reconstruction of thoracic aortic dissection by stent-grafts placement. N Egl J Med. 1999;340:1539-45.

  8. Dake MD, Kato N, Mitchell RS, et al. Endovascular stent-graft placement for the treatment of acute aortic dissection. N Engl J Med. 1999;340:1546-52.

  9. Svensson LG, Kouchoukos NT, Miller C. Expert consensus document on the treatment of descending thoracic aortic disease using endovascular stent-grafts. Ann Thorac Surg. 2008;85:S1-41.

  10. Hiratzka LF, Bakris GL, Beckman JA, et al. 2010 ACCF/AHA/AATS/ACR/ ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the diagnosis and management of patients with thoracic aortic disease: executive summary. J Am Coll Cardiol. 2010;55:1509-1544.

  11. Trimarchi S, Eagle KA, Nienaber CA, et al. Importance of refractory pain and hypertension in acute type B aortic dissection. Insights from the international registry of acute aortic dissection (IRAD). Circulation. 2010;122:1283-9.

  12. Fattori R, Tsai TT, Myrmel T, et al. Complicated acute type B dissection: Is surgery still the best option?: a report from the International Registry of Acute Aortic Dissection. JACC Cardiovasc Interv. 2008;1(4):395-402.

  13. Kato N, Hirano T, Ishida M, et al. Acute and contained rupture of the descending thoracic aorta: treatment with endovascular stent graft. J Vasc Surg. 2003;37:100-5.

  14. Doss M, Balzer J, Martens S, et al. Surgical versus endovascular treatment of acute thoracic aortic rupture: a single-center experience. Ann Thorac Surg. 2003;76:1465-70.

  15. Scheinert D, Krankenberg H, Schmidt A, et al. Endoluminal stent-graft placement for acute rupture of the descending thoracic aorta. Eur Heart J. 2004;25:694-700.

  16. Jonker FH, Verhagen H, Lin P, et al. Outcomes of endovascular repair of ruptured descending thoracic aortic aneurysms. Circulation. 2010;121:2718-23.

  17. Patel HJ, Williams DM, Upchurch GR, Dasika NL, Deeb GM. A comparative analysis of open and endovascular repair for the ruptured descending thoracic aorta. J Vasc Surg. 2009;50:1265-70.

  18. Jonker FH, Verhagen HJ, Lin PH, et al. Open surgery versus endovascular repair of ruptured thoracic aortic aneurysms. J Vasc Surg. 2011;53:1210-6.

  19. Jonker FH, Trimarchi S, Verhagen H, Moll FL, Sumpio BE, Muhs BE. Meta-analysis of open versus endovascular repair for ruptured descending thoracic aortic aneurysm. J Vasc Surg. 2010;51:1026-32.

  20. O`Donnell S, Geotchues A, Beavers F, et al. Endovascular management of acute aortic dissections. J Vasc Surg. 2011;54:1283-9.

  21. Tsai TT, Trimarchi S, Nienaber CA. Acute aortic dissection: perspective from the International Registry of Aortic Dissection (IRAD). Eur J Vasc Endovasc Surg. 2009;37:149-59.

  22. Manning BJ, Dias N, Manno M, et al. Endovascular treatment of acute complicated type B dissection: morphological changes at mid-term follow-up. J Endovasc Ther. 2009;16:466-74.

  23. Patel HJ, Williams DM, Meekov M, Dasika NL, Upchurch GR, Deeb GM. Long-term results of percutaneous management of malperfusion in acute type B aortic dissection: implications for thoracic endovascular repair. J Thorac Cardiovasc Surg. 2009;138:300-8.

  24. Sachs T, Pomposelli F, Hagberg R, et al. Open and endovascular repair of type B aortic dissection in the Nationwide Inpatient Sample. J Vasc Surg. 2010;52:860-6.

  25. Xenos ES, Abedi NN, Davenport DL, et al. Meta-analysis of endovascular vs open repair for traumatic descending thoracic aortic rupture. J Vasc Surg. 2008;48:1343-51.

  26. Eggebrecht H, Plicht B, Kahlert P, Erbel R. Intramural hematoma and penetrating ulcers: indications to endovascular treatment. Eur J Vasc Endovasc Surg. 2009;38:659-65.

  27. Harris KM, Braverman AC, Eagle KA, et al. Acute aortic hematoma: An analysis from the international registry of acute aortic dissection. Circulation. 2012;126:S91-6.

  28. Evangelista A, Salas A, Ribera A, et al. Long-term outcome of aortic dissection with patent false lumen. Predictive role of entry tear and location. Circulation. 2012;125:3133-41.

  29. Ince H, Rehders T, Petzsch M, Kische S, Nienaber C. Stent-graft in patients with Marfan syndrome. J Endovasc Ther. 2005;12:82-8.

  30. Gaxotte V, Thony F, Rousseau H, et al. Midterm results of aortic diameter outcomes after thoracic sstent-graft implantation for aortic dissection: A multicenter study. J Endovasc Ther. 2006;13:127-38.

  31. Geisbusch P, Kotelis D, von Tengg-Kobligk H, Hyhlik-Durr A, Allenger JR, Bokler D. Thoracic aortic endografting in patients with connective tissue diseases. J Endovasc Ther. 2008;15:144-9.

  32. Marcheix B, Rosseau H, Bongard V, et al. Stent grafting of dissected descending aorta in patients with Marfan´s syndrome. Mid-term results. JACC Cardiovasc Interv. 2008;1(6):673-80.

  33. Cooper DG, Walsh SR, Sadat U, Hayes PD, Boyle JR. Treating the thoracic aorta in Marfan syndrome: Surgery or TEVAR. J Endovasc Ther. 2009;16:60-70.

  34. Eid-Lidt G, Ramirez S, Damas DF, Cervantes J. Aortic remodeling after thoracic aortic stent-graft in patients with Marfan syndrome. Am J Cardiol. 2008;102:222i-23i [abstract].




2020     |     www.medigraphic.com